Developing PKCe-Degrading PROTACs as Dual-Action Agents to Treat Type 2 Diabetes

  • Schmitz-Peiffer, Carsten (Primary Chief Investigator (PCI))
  • Scanlon, Martin (Chief Investigator (CI))

Project: Research

Project Details

Short titlePKCe
StatusNot started